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Correlation between erythromycin and azithromycin
resistance in Streptococcus pneumoniae
To the Editor: Erythromycin has long been used as an
alternative to penicillin for the treatment of upper and lower
respiratory tract infections in children.  Modifications of the
original chemical structure of erythromycin have produced
macrolides such as azithromycin that have improved
therapeutic properties. Azithromycin given as a single daily
dose for 3 days is used for the treatment of acute group A
streptococcal pharyngitis1 and a meta-analysis of randomised
controlled trials found 30 mg/kg of azithromycin, given over 
3 - 5 days, to be as effective as longer courses of other
antibiotics for the treatment of upper respiratory tract
infections.2 There have, however, been recent reports of
macrolide resistance resulting in azithromycin failure for the
treatment of group A streptococcal pharyngitis.3
In South Africa, azithromycin is frequently prescribed for the
treatment of acute otitis media in children; however, the
increasing prevalence of erythromycin resistance in
Streptococcus pneumoniae isolates may adversely affect the
efficacy of this therapy. A survey of pneumococci isolated from
blood and cerebrospinal fluid (CSF) of children in the public
sector of South Africa between 1991 and 1998 found a small but
statistically significant increase in resistance to erythromycin,
from 1.8% of pneumococci isolated between 1991 and 1994 to
4.2% of  pneumococci isolated from 1995 to 1998.4 In contrast,
39% of pneumococci carried in the nasopharynx of children
aged 1 month - 5 years who were sampled prospectively while
attending private paediatricians in Johannesburg were resistant
to erythromycin.5
To evaluate the correlation between resistance to
erythromycin and azithromycin, 100 erythromycin-resistant 
S. pneumoniae isolates (minimum inhibitory concentrations
MICs) ranged from 1µg/ml to > 256 µg/ml were tested for
concomitant resistance to azithromycin.  The isolates had been
obtained from middle-ear fluid of children with acute otitis
media (N = 34), cases of invasive pneumococcal disease 
(N = 19), and from the nasopharynx of asymptomatic children
(N = 47).  MICs were determined by agar dilution (100 isolates)
and E-test (98 isolates) using standardised methods and criteria
for determination of resistance.6 The azithromycin powder and
methods for susceptibility testing were obtained from the
manufacturer. For the pneumococci tested, the MICs for
azithromycin correlated with the MICs for erythromycin for
100% of the isolates using both the agar dilution and E-test
methods.   Therefore, resistance to erythromycin can be used as
a surrogate for resistance to azithromycin.  Similar results were
found in a study of 120 isolates from the USA.7
In addition, a study of the impact of azithromycin on
carriage of antibiotic-resistant pneumococci found that 5 days
of azithromycin treatment resulted in a four-fold increase in the
prevalence of erythromycin-resistant pneumococci.8 These
results suggest that in South Africa, where erythromycin-
resistant pneumococci are common, macrolide treatment for
otitis media infections in children under 4 years of age may
have reduced efficacy.
Avril D Wasas
Robin E Huebner
Maurice Hockman
Medical Research Council/National Health Laboratory Service/University of the
Witwatersrand Respiratory and Meningeal Pathogens Research Unit
National Health Laboratory Service
Johannesburg
Keith P Klugman
Medical Research Council/National Health Laboratory Service/University of the
Witwatersrand Respiratory and Meningeal Pathogens Research Unit
National Health Laboratory Service
Johannesburg, and
Rollins School of Public Health
Emory University
Atlanta
USA
1. Pfizer Laboratories (Pty) Ltd.  Zithromax (azithromycin) package insert. 20 September 1993.
2. Ioannidis JP, Contopoulos-Ioannidis DG, Chew P, Lau J. Meta-analysis of randomized
controlled trials on the comparitive efficacy and safety of azithromycin against other
antibiotics for upper respiratory tract infections.  J Antimicrob Chemother 2001; 48: 677-689.
3. Bingen E, Leclercq R, Fitoussi F, et al. Emergence of group a streptococcus strains with
different mechanisms of macrolide resistance. Antimicrob Agents Chemother 2002; 46: 1199-
1203. 
4. Huebner RE, Wasas, AD, Klugman KP. Trends in antimicrobial resistance and serotype
distribution of blood and cerebrospinal fluid isolates of Streptococcus pneumoniae in South
Africa, 1991-1998.  Int J Infect Dis 2000; 4: 214-218.
5. Huebner RE, Wasas AD, Klugman KPand the Paediatric Study Group. Prevalence of
nasopharyngeal antibiotic-resistant pneumococcal carriage in children attending private
paediatric practices in Johannesburg. S Afr Med J 2000; 90: 1116-1121.
6. National Committee for Clinical Laboratory Standards. Performance Standards for Antimicrobial
Susceptibility Testing: Twelfth Informational Supplement.  NCCLS document M100-S12.
Villanova, Pennsylvania: National Committee for Clinical Laboratory Standards, 2002.
7. Ednie LM, Visalli MA, Jacobs MR, Appelbaum PC. Comparative activities of clarithromycin,
erythromycin, and azithromycin against penicillin-susceptible and penicillin-resistant
pneumococci. Antimicrob Agents Chemother 1996; 40: 1950-1952.
8. Morita JY, Kahn E, Thompson T, et al. Impact of azithromycin on oropharyngeal carriage of
Group A Streptococcus and nasopharyngeal carriage of macrolide-resistant Streptococcus
pneumoniae. Pediatr Infect Dis J 2000; 19: 41-46.
